Oregon Department of Corrections
Approved Formulary
Search by name
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
February P&T meeting minutes have been posted.
Oregon Department of Corrections
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions
Webpage Links
Search results for:
leflunomide
leflunomide
Hazardous Drugs
Handling Guide (Group 2: Non-Antineoplastic)
Cell Status
NFISA
Brand names:
ARAVA
Form
Strength
TABLET, ORAL
10mg; 20mg
Additional Information:
OCTOBER 2017 P&T MINUTES
AUGUST 2014 P&T MINUTES
Last updated:
Dec. 19, 2022
Added to Formulary:
10/2017
Black Box Warning:
Pregnancy risk
FDA Drug Safety:
Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research for Arava (leflunomide) oral tablets, 10mg, 20mg, 100mg
UpToDate
Micromedex
Pharmacist's Letter
FDA DailyMed Package Insert
WebMD Pill Identifier
OCTOBER 2017 P&T MINUTES
AUGUST 2014 P&T MINUTES